Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Dermatology  |  Family Medicine

Search Medical Condition
Please enter condition
Please choose location from dropdown

Acne Clinical Trials

A listing of Acne medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (152) clinical trials

A 52-week, multicenter, randomized, double-blind study of secukinumab (300mg) to demonstrate efficacy as assessed by psoriasis area and severity index and investigator's global assessment after 12 weeks of treatment, compared to ustekinumab, and to assess long-term safety, tolerability, and efficacy in subjects with moderate to severe plaque psoriasis.

Phase

Looking for patients at least 18 years of age and diagnosed with HS.  

Phase N/A

The purpose of this study is to demonstrate superiority of secukinumab at Week 16, based on Hidradenitis Suppurativa Clinical Response (HiSCR) rates versus placebo, along with the maintenance of efficacy of secukinumab at Week 52 in subjects with moderate to severe HS. Moreover, this study will also assess the safety ...

Phase

The objective of this study is to evaluate the effectiveness of the study medication in those with moderate to severe hidradenitis suppurativa. This study is a 44-week study with up to 13 office visits.  

Phase

Bioequivalence Study of Clindamycin Phosphate Topical Lotion, 1% in Subjects With Acne Vulgaris  

Phase N/A

Physical exam and assessments of study condition to be provided at no cost by an experienced provider. No insurance necessary. Compensation will be provided at the end of study participation.    

Phase N/A

The 12-week, phase 2 study is intended to evaluate the safety and efficacy of IDP-126 Gel, a novel fixed-dose combination of clindamycin phosphate, benzoyl peroxide and adapalene relative to placebo and dual component combinations for the treatment of acne vulgaris in subjects 9 years of age and older. All subjects will ...

Phase

Primary end point: To evaluate the safety and tolerability of INCB054707. Secondary end point: To evaluate the systemic exposure and evaluate the efficacy of INCB054707. Overall design: This is a Phase 2, multicenter, open-label, single-arm study to assess the safety of 15 mg QD INCB054707 over 8 weeks in men and women aged 18 ...

Phase

The main purpose of this study is to evaluate the safety, efficacy, and tolerability of a once-daily topical application of IDP-126 Gel in subjects with moderate to severe acne. Subjects must be at least 9 years of age or older and generally healthy. IDP-126 Gel is a fixed dose combination ...

Phase

The main purpose of this study is to compare the safety, efficacy, and tolerability of a once-daily topical application of IDP-123 Lotion compared to the IDP-123 Vehicle Lotion in subjects with moderate to severe acne. Subjects must be at least 9 years of age or older and generally healthy. IDP-123 ...

Phase